Daily Practice Assessment of <i>KRAS</i> Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner

<i>KRAS</i> mutations are among the most frequent genomic alterations identified in non-squamous non-small cell lung carcinomas (NS-NSCLC), notably in lung adenocarcinomas. In most cases, these mutations are mutually exclusive, with different genomic alterations currently known to be sen...

Full description

Bibliographic Details
Main Authors: Christophe Bontoux, Véronique Hofman, Patrick Brest, Marius Ilié, Baharia Mograbi, Paul Hofman
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/7/1628